Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia

Chengcheng Pu,1,* Bingjie Huang,1,* Tianhang Zhou,1 Zhang Cheng,1 Yi Wang,2 Chuan Shi,1 Xin Yu1 1Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking Uni...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pu C, Huang B, Zhou T, Cheng Z, Wang Y, Shi C, Yu X
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	first-episode schizophrenia gender difference antipsychotic treatment treatment response side effects Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/cf30e069d0a847679ce7310f52cb8fbb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cf30e069d0a847679ce7310f52cb8fbb
record_format	dspace
spelling	oai:doaj.org-article:cf30e069d0a847679ce7310f52cb8fbb2021-12-02T12:03:04ZGender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia1178-2021https://doaj.org/article/cf30e069d0a847679ce7310f52cb8fbb2020-12-01T00:00:00Zhttps://www.dovepress.com/gender-differences-in-the-first-year-antipsychotic-treatment-for-chine-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Chengcheng Pu,1,* Bingjie Huang,1,* Tianhang Zhou,1 Zhang Cheng,1 Yi Wang,2 Chuan Shi,1 Xin Yu1 1Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, People’s Republic of China; 2Neuropsychology and Applied Cognitive Neuroscience Laboratory, CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Department of Psychology, University of Chinese Academy of Sciences, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xin Yu; Chuan ShiPeking University Sixth Hospital, 51 Huayuan North Road, Beijing 100089, People’s Republic of ChinaEmail yuxin@bjmu.edu.cn; shichuan@bjmu.edu.cnObjective: To investigate the gender differences in the efficacy and side effects of three frequently used antipsychotic medicines (risperidone, olanzapine, aripiprazole) for patients with first-episode schizophrenia during the first year of treatment.Methods: A total of 569 patients with first-episode schizophrenia were randomly assigned to risperidone, olanzapine, and aripiprazole groups. All patients were treated according to their actual clinical needs. Clinical efficacies were assessed by the Positive and Negative Symptom Scale (PANSS) and side effects were assessed by the Udvalg for Kliniske Undersogelser Side-Effect scale (UKU). All assessments were completed at baseline and at 1, 2, 3, 6, 9, and 12 months.Results: Males had higher baseline PANSS total scores and PANSS negative and general pathological scores. No significant interactions were found between treatment time and gender in psychopathology improvements in all three groups. In the end of the first year, female patients receiving risperidone reported more dermatological symptoms (rashes) than males, female patients receiving olanzapine reported more autonomic side effects and dermatological symptoms than males, and female patients receiving aripiprazole reported more psychotic side effects than males.Conclusion: Gender differences exhibited in response to antipsychotic treatments for Chinese patients with first-episode schizophrenia. After the first year of antipsychotic treatment, drug-related side effects were more likely presented in female patients than male patients.Keywords: first-episode schizophrenia, gender difference, antipsychotic treatment, treatment response, side effectsPu CHuang BZhou TCheng ZWang YShi CYu XDove Medical Pressarticlefirst-episode schizophreniagender differenceantipsychotic treatmenttreatment responseside effectsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 16, Pp 3145-3152 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	first-episode schizophrenia gender difference antipsychotic treatment treatment response side effects Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	first-episode schizophrenia gender difference antipsychotic treatment treatment response side effects Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Pu C Huang B Zhou T Cheng Z Wang Y Shi C Yu X Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
description	Chengcheng Pu,1,* Bingjie Huang,1,* Tianhang Zhou,1 Zhang Cheng,1 Yi Wang,2 Chuan Shi,1 Xin Yu1 1Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, People’s Republic of China; 2Neuropsychology and Applied Cognitive Neuroscience Laboratory, CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Department of Psychology, University of Chinese Academy of Sciences, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xin Yu; Chuan ShiPeking University Sixth Hospital, 51 Huayuan North Road, Beijing 100089, People’s Republic of ChinaEmail yuxin@bjmu.edu.cn; shichuan@bjmu.edu.cnObjective: To investigate the gender differences in the efficacy and side effects of three frequently used antipsychotic medicines (risperidone, olanzapine, aripiprazole) for patients with first-episode schizophrenia during the first year of treatment.Methods: A total of 569 patients with first-episode schizophrenia were randomly assigned to risperidone, olanzapine, and aripiprazole groups. All patients were treated according to their actual clinical needs. Clinical efficacies were assessed by the Positive and Negative Symptom Scale (PANSS) and side effects were assessed by the Udvalg for Kliniske Undersogelser Side-Effect scale (UKU). All assessments were completed at baseline and at 1, 2, 3, 6, 9, and 12 months.Results: Males had higher baseline PANSS total scores and PANSS negative and general pathological scores. No significant interactions were found between treatment time and gender in psychopathology improvements in all three groups. In the end of the first year, female patients receiving risperidone reported more dermatological symptoms (rashes) than males, female patients receiving olanzapine reported more autonomic side effects and dermatological symptoms than males, and female patients receiving aripiprazole reported more psychotic side effects than males.Conclusion: Gender differences exhibited in response to antipsychotic treatments for Chinese patients with first-episode schizophrenia. After the first year of antipsychotic treatment, drug-related side effects were more likely presented in female patients than male patients.Keywords: first-episode schizophrenia, gender difference, antipsychotic treatment, treatment response, side effects
format	article
author	Pu C Huang B Zhou T Cheng Z Wang Y Shi C Yu X
author_facet	Pu C Huang B Zhou T Cheng Z Wang Y Shi C Yu X
author_sort	Pu C
title	Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
title_short	Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
title_full	Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
title_fullStr	Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
title_full_unstemmed	Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
title_sort	gender differences in the first-year antipsychotic treatment for chinese first-episode schizophrenia
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/cf30e069d0a847679ce7310f52cb8fbb
work_keys_str_mv	AT puc genderdifferencesinthefirstyearantipsychotictreatmentforchinesefirstepisodeschizophrenia AT huangb genderdifferencesinthefirstyearantipsychotictreatmentforchinesefirstepisodeschizophrenia AT zhout genderdifferencesinthefirstyearantipsychotictreatmentforchinesefirstepisodeschizophrenia AT chengz genderdifferencesinthefirstyearantipsychotictreatmentforchinesefirstepisodeschizophrenia AT wangy genderdifferencesinthefirstyearantipsychotictreatmentforchinesefirstepisodeschizophrenia AT shic genderdifferencesinthefirstyearantipsychotictreatmentforchinesefirstepisodeschizophrenia AT yux genderdifferencesinthefirstyearantipsychotictreatmentforchinesefirstepisodeschizophrenia
_version_	1718394775394058240

Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia

Ejemplares similares